Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Manufacturing of Fluorouracil 5% Cream (Topical)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the full-scale manufacturing of Fluorouracil 5% Cream, a topical medication, encompassing all stages from formulation to quality control, batch testing, and ensuring regulatory compliance. This production is intended for distribution to government agencies, specifically the Department of Veterans Affairs through Nac Pharmaceuticals. The scope includes maintaining high standards in manufacturing processes to meet both therapeutic efficacy and safety standards as mandated by regulatory authorities. Issued as a subcontract with no specified set-aside, the contract falls under the NAICS code 325412, relating to pharmaceutical preparation manufacturing. The solicitation was posted on June 1, 2026, with a response deadline set for June 22, 2026. While specific geographic details for the place of performance and agency contact information are not provided, the contract is designed to support government healthcare needs by supplying a vital topical chemotherapy cream, maximizing availability through government channels.

General Info

Manufacture and supply Fluorouracil 5% Cream to Department of Veterans Affairs, ensuring compliance.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Full-scale manufacturing of Fluorouracil 5% Cream including formulation, quality control, batch testing, and regulatory compliance for government distribution.

Similar Contracts

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

2 days ago

DEADLINE

in 20 days
View Details